This fresh series of experiments increases the impressive data package for COTI-2.

COTI’s novel small molecule effective against pancreatic tumor in animal model Critical Outcome Technologies Inc. announced more excellent results today from pet experiments completed at a prominent Canadian cancer tumor research facility online cialis india http://tadalis-reviews.com . This fresh series of experiments increases the impressive data package for COTI-2, demonstrating efficacy both as a single agent and in conjunction with current first series therapies, in addition to low toxicity in several different animal models of individual cancers.